Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicriviroc in HIV-Infected Children and Adolescents
NCT00766597Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vicriviroc in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2009; status: completed.
02
Drugs
vicriviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00766597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766597.